Literature DB >> 18085203

Culture and characterization of human bone marrow mesenchymal stem cells.

Bruno Delorme1, Pierre Charbord.   

Abstract

Bone marrow (BM) mesenchymal stem cells (MSCs) are non-hematopoietic cells capable of generating colonies of plastic-adherent marrow mesenchymal cells, each derived from a single cell termed a colony-forming unit fibroblasts (CFU-Fs). In addition to their role in establishing the marrow microenvironment, these cells have been shown to differentiate into several types of mesenchymal and non-mesenchymal lineages. Because of their multipotency, MSCs represent an attractive cellular source in the promising field of cellular therapy. In this chapter, we will focus on culture conditions for human BM MSC expansion and CFU-F assays. We also describe the methodologies to analyze the primary cultures obtained, both at the phenotypic and at the functional levels. Phenotypically, MSCs can be defined with a minimal set of markers as CD31-, CD34-, and CD45-negative cells and CD13-, CD29-, CD73-, CD90-, CD105-, and CD166-positive cells. Functionally, we describe the culture conditions (specific media and cellular preparations) for in vitro differentiation of MSCs into the adipogenic, osteogenic, and chondrogenic lineages. The corresponding colorimetric assays (oil red O, Von Kossa and alizarin red S, and safranin O and alcian blue stains, respectively) are also described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085203     DOI: 10.1007/978-1-59745-443-8_4

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  48 in total

Review 1.  Molecular mediators of mesenchymal stem cell biology.

Authors:  Maria P Alfaro; Sarika Saraswati; Pampee P Young
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

2.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.

Authors:  Jessica L Lo Surdo; Bryan A Millis; Steven R Bauer
Journal:  Cytotherapy       Date:  2013-08-29       Impact factor: 5.414

3.  Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokines.

Authors:  S K Brusnahan; T R McGuire; J D Jackson; J T Lane; K L Garvin; B J O'Kane; A M Berger; S R Tuljapurkar; M A Kessinger; J G Sharp
Journal:  Mech Ageing Dev       Date:  2010-10-28       Impact factor: 5.432

4.  Chitosan/gelatin scaffolds support bone regeneration.

Authors:  Anthie Georgopoulou; Fotios Papadogiannis; Aristea Batsali; John Marakis; Kalliopi Alpantaki; Aristides G Eliopoulos; Charalampos Pontikoglou; Maria Chatzinikolaidou
Journal:  J Mater Sci Mater Med       Date:  2018-05-05       Impact factor: 3.896

Review 5.  Mesenchymal stem cells in joint disease and repair.

Authors:  Frank Barry; Mary Murphy
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

6.  Human mesenchymal stem cell differentiation on self-assembled monolayers presenting different surface chemistries.

Authors:  Jennifer E Phillips; Timothy A Petrie; Francis P Creighton; Andrés J García
Journal:  Acta Biomater       Date:  2009-07-24       Impact factor: 8.947

7.  Breast cancer cells promote osteoblastic differentiation via Sema 3A signaling pathway in vitro.

Authors:  Wei-Wei Shen; Wu-Gui Chen; Fu-Zhou Liu; Xu Hu; Hong-Kai Wang; Ying Zhang; Tong-Wei Chu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

8.  Bone marrow-derived mesenchymal stem cells reduce immune reaction in a mouse model of allergic rhinitis.

Authors:  Ning Zhao; Yanjuan Liu; Hongfeng Liang; Xuejun Jiang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

9.  Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

Authors:  Charalampos Pontikoglou; Maria-Christina Kastrinaki; Mirjam Klaus; Christina Kalpadakis; Pavlos Katonis; Kalliopi Alpantaki; Gerassimos A Pangalis; Helen A Papadaki
Journal:  Stem Cells Dev       Date:  2013-02-01       Impact factor: 3.272

10.  Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation.

Authors:  Zahia Hamidouche; Olivia Fromigué; Jochen Ringe; Thomas Häupl; Pierre J Marie
Journal:  BMC Cell Biol       Date:  2010-06-23       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.